← Back to Patent Explorer
US4223004A Expired / Lapsed US ⏱️ 0.0 years remaining

Drug compositions

Assignee: University of Toronto
•
Filing: 1977-05-23
•
Granted: 1980-09-16
•
Expires: 1997-05-23
📄 Original PDF 🌐 Google Patents

Abstract

Abstract Monitorable drug compositions contain known proportions by weight of a drug e.g. methadone and an isotopic analogue e.g. deuterated methadone. A urine specimen or blood specimen can be tested to reveal whether the proportion of the two constituents in the urine is the same as the proportion in the composition that was prescribed to the patient. A discrepancy will reveal that the patient has supplemented his dosage with drugs obtained from another source.

Inventors

  • 👤 Jen C. Hsia
  • 👤 Arthur E. Le Blanc
  • 👤 Joan A. Marshman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 05:09
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/94; G01N33/9486; A; A61; A61K; A61K49/00; A61K49/0004; A61K51/00; A61K51/02; A61K51/04; G01N33/946; G01N33/948; A61K2123/00; Y; Y10; Y10T; Y10T436/00; Y10T436/13; Y10T436/14; Y10T436/141111; Y10T436/24

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 217 words
A method for detecting unauthorized supplementation of a prescribed pharmacological dosage given to a patient, comprising the steps of: (a) providing a drug composition comprising a pharmacologically-active compound and a radiologically stable, isotopically distinct analogue having the same molecular structure as said compound and containing at least one radiologically-stable isotopic atom, said compound and said analogue being present in a first ratio by weight; (b) providing the patient with a prescribed dosage of the composition; (c) subsequently obtaining a physiological specimen of body fluid from the patient; (d) subjecting the specimen to analysis to determine a first value indicative of the weight of a substance selected from the group consisting of said compound and its metabolites, and a second value indicative of the weight of a substance selected from the group consisting of said analogue and its corresponding metabolites; and (e) deriving from said first and second values a second ratio indicative of the ratio of the weight of said compound previously ingested by said patient and present in his metabolism to the weight of said analogue previously ingested by said patient and present in his metabolism; whereby said first ratio can be compared with said second ratio, so that any discrepancy between said first and second ratios indicative of unauthorized supplementation of dosage can be revealed.
Claim 2
Independent Claim 217 words
A method for detecting unauthorized supplementation of a prescribed pharmacological dosage given to a patient, comprising the steps of: (a) providing a drug composition comprising a pharmacologically-active compound and a radiologically stable, isotopically distinct analogue having the same molecular structure as said compound and containing at least one radiologically-stable isotopic atom, said compound and said analogue being present in a first ratio by weight; (b) providing the patient with a prescribed dosage of the composition; (c) subsequently obtaining a physiological specimen of body fluid from the patient; (d) subjecting the specimen to analysis to determine a first value indicative of the weight of a substance selected from the group consisting of said compound and its metabolites, and a second value indicative of the weight of a substance selected from the group consisting of said analogue and its corresponding metabolites; and (e) deriving from said first and second values a second ratio indicative of the ratio of the weight of said compound previously ingested by said patient and present in his metabolism to the weight of said analogue previously ingested by said patient and present in his metabolism; whereby said first ratio can be compared with said second ratio, so that any discrepancy between said first and second ratios indicative of unauthorized supplementation of dosage can be revealed.
Claim 3
Dependent Claim 18 words
A method as claimed in claim 1 in which the compound and the analogue are both isotopically labeled.
Claim 4
Dependent Claim 21 words
A method as claimed in claim 1 in which the drug composition comprises methadone mixed with a deuterated analogue of methadone.
Claim 5
Dependent Claim 14 words
A method as claimed in claim 3 wherein the deuterated analogue is 1,1,1-trideuterio methadone.
Claim 6
Dependent Claim 23 words
A method as claimed in claim 1 wherein said compound is selected from the group consisting of opiates, amphetamines, synthetic opiates, and barbiturates.
Claim 7
Dependent Claim 23 words
A method as claimed in claim 1 wherein said compound is selected from the group consisting of methadone, acetyl methadol, morphine, and heroin.
Claim 8
Dependent Claim 53 words
A method as claimed in claim 1 wherein step (d) comprises subjecting a gas chromatographic fraction of said specimen to repetitive mass spectrographic scan and comparing areas under the mass spectrographic curves representing cumulative ion currents for mass fragments that are indicative of the weight ratios of said compound and isotopic analogues thereof.
Claim 9
Independent Claim 215 words
A method for detecting unauthorized usage of a pharmacologically-active chemical compound prescribed to a plurality of patients undergoing a course of therapy comprising: (a) providing for said plurality of patients a corresponding plurality of mutually distinctively-labeled drug compositions, each said composition comprising said compound and at least one radiologically stable isotopically distinct analogue having the same molecular structure as said compound and containing at least one radiologically-stable isotopic atom and each composition being distinguished from each other composition by the presence of said radiologically stable isotopically distinct analogue (b) administering a prescribed dosage of said compositions to the patients, each patient receiving a different composition; (c) obtaining a physiological specimen of a body fluid from a person suspected of receiving amounts of said compositions diverted from at least one patient in the group; (d) subjecting said specimen to analysis to determine in said specimen values indicative of weights of substances selected from the group consisting of: (i) said compound and each isotopic analogue thereof; and (ii) metabolites of said compound and corresponding metabolites of said isotopic analogues; and (e) deriving from said values a weight ratio indicative of the relative amounts of said compound and of said analogues ingested by the person undergoing testing, whereby an indication of diversion of said compositions may be obtained.
Claim 10
Independent Claim 215 words
A method for detecting unauthorized usage of a pharmacologically-active chemical compound prescribed to a plurality of patients undergoing a course of therapy comprising: (a) providing for said plurality of patients a corresponding plurality of mutually distinctively-labeled drug compositions, each said composition comprising said compound and at least one radiologically stable isotopically distinct analogue having the same molecular structure as said compound and containing at least one radiologically-stable isotopic atom and each composition being distinguished from each other composition by the presence of said radiologically stable isotopically distinct analogue (b) administering a prescribed dosage of said compositions to the patients, each patient receiving a different composition; (c) obtaining a physiological specimen of a body fluid from a person suspected of receiving amounts of said compositions diverted from at least one patient in the group; (d) subjecting said specimen to analysis to determine in said specimen values indicative of weights of substances selected from the group consisting of: (i) said compound and each isotopic analogue thereof; and (ii) metabolites of said compound and corresponding metabolites of said isotopic analogues; and (e) deriving from said values a weight ratio indicative of the relative amounts of said compound and of said analogues ingested by the person undergoing testing, whereby an indication of diversion of said compositions may be obtained.
Claim 11
Dependent Claim 34 words
A method as claimed in claim 8 wherein at least one of said compositions is distinguished from each other of said compositions by having a different weight ratio of said compound to said analogue.
Claim 12
Dependent Claim 34 words
A method as claimed in claim 8 wherein at least one of said compositions is distinguished from each other of said compositions by having a different number of isotopic atoms present in said analogue.
Claim 13
Dependent Claim 32 words
A method as claimed in claim 8 wherein at least one of said compositions is distinguished from each other of said compositions by having a different element isotopically replaced in said analogue.
Claim 14
Dependent Claim 53 words
A method as claimed in claim 8 wherein step (d) comprises subjecting a gas chromatographic fraction of said specimen to repetitive mass spectrographic scan and comparing areas under the mass spectrographic curves representing cumulative ion currents for mass fragments that are indicative of the weight ratios of said compound and isotopic analogues thereof.
Claim 15
Dependent Claim 17 words
A method as claimed in claim 8 wherein said compound, and each analogue thereof, is isotopically labeled.
Claim 16
Dependent Claim 18 words
A method as claimed in claim 8 wherein said compositions comprise methadone mixed with deuterated analogues of methadone.
Claim 17
Dependent Claim 17 words
A method as claimed in claim 14 wherein said deuterated analogues comprise mono-deuterated, di-deuterated and tri-deuterated methadone.
Claim 18
Dependent Claim 23 words
A method as claimed in claim 8 wherein said compound is selected from the group consisting of opiates, amphetamines, synthetic opiates, and barbiturates.
Claim 19
Dependent Claim 23 words
A method as claimed in claim 8 wherein said compound is selected from the group consisting of methadone, acetyl methadol, morphine, and heroin.

References Cited (Backward Citations)

US3275416A Cited
US3867366A Cited
US3847138A Cited
US4022876A Cited
US3915639A Cited
US3873270A Cited
US3993741A Cited
US3901655A Cited
US4049683A Cited
US4036823A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-09-16 1984-03-17 1984-09-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-09-16 1988-03-17 1988-09-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-09-16 1992-03-17 1992-09-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag